Methods and compositions for inducing tumor-specific cytotoxicity
CA 2464394 A1 · Owner: Hochberg, Abraham · Inventors: Hochberg, Abraham; Ayesh, Suhail
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to tumor-specific viral replication and/or expression using conditionally replicative viral vectors in which the expression of a gene product essential for viral replication is controlled by an H19 regulatory sequence. The invention provides such viral vectors methods of , making such vectors and methods of administering such vectors. The compositions and methods of the invention are useful in the treatment of cancer and hyperproliferative disorders.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 22, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 22, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 22, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.